In this way, although it has an impressive AI platform, Absci faces the major hurdle common to all early-stage biotech companies: scaling up from success in the lab to clinical success and ...
The biotech world is a prime target for risk-tolerant investors seeking out companies with the potential for dramatic gains. Firms in this space often either make it big—spiking upon news of a ...
Fifth-generation AMD EPYC processors and RDMA cluster networking power OCI’s bare metal instances. They provide Absci with the low-latency networking and throughput required for large-scale model ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する